glp-1 receptor agonist drugs list Market Overview: Agonists and the Obesity Market | Blog list of glp 1 medications
Description
In addition to its effects on insulin, GIP plays a crucial role in fat accumulation by promoting the activity of adipocyte-expressed lipoprotein lipase and promoting bone formation by preventing osteoclast apoptosis, as evidenced by the thinner bone trabeculae seen in mice lacking GIP receptors [20,21,22]
If phase 3 results remain positive, regulatory submissions may begin in 2026, meaning orforglipron could become available in late 2026 or 2027, depending on MHRA and NICE approval timelines
Read on to learn more about boxed warnings and examples of drugs that carry these warnings
Cardiovascular Benefits : Some GLP-1 receptor agonists have shown to reduce the risk of cardiovascular events like heart attacks and strokes in people with type 2 diabetes
March 3, 2026
But tens of thousands of people have studied these proteins and made new and better versions
